Definitive IMRT for Stage III Thymic Carcinoma: A Brief Report and Literature Review
IntroductionThymic carcinoma is a rare malignancy often presenting at an advanced stage. Radiosurgery and chemotherapy are often the only treatment options available to physicians.MethodsA 70-year old man presented with an unresectable Stage III thymic tumor and was treated with 45Gy in 12 fractions...
Main Authors: | Sarah Dooley, Carryn Marie Anderson |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-10-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2016.00219/full |
Similar Items
-
The long-term survival of patients with III-IVb stage nasopharyngeal carcinoma treated with IMRT with or without Nimotuzumab: a propensity score-matched analysis
by: Wang Zhi-Qiang, et al.
Published: (2019-11-01) -
Chemotherapy in the treatment of thymic tumors
by: Marcello Tiseo, et al.
Published: (2011-12-01) -
Chemotherapy and prognosis in advanced thymic carcinoma patients
by: Zhengbo Song, et al.
Published: (2015-12-01) -
Evaluation of Surgical Therapy in Advanced Thymic Tumors
by: Till Markowiak, et al.
Published: (2021-09-01) -
Single Centre Experience in the Management of Thymic Tumours
by: Muhammad Farooq Latif, et al.
Published: (2013-01-01)